Characteristics and in-hospital mortality of diabetics and nondiabetics with an acute coronary syndrome; the GREECS study

Clinical Cardiology

Volumn 30, Issue 5, 2007, Pages 239-244

  Pitsavos, Christos ^a   Kourlaba, Georgia ^a,c   Panagiotakos, Demosthenes B ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c NONE   (Greece)

Author keywords

Acute coronary syndromes; Antidiabetic treatment; Diabetes mellitus; In hospital mortality

Indexed keywords

FIBRINOLYTIC AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; RURAL AREA; URBAN AREA;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX;

EID: 34249051590     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.20078     Document Type: Article

References (18)

1. Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, et al.: Impact of diabetes on mortality after the first myocardial infarction: the FINMONICA Myocardial Infarction Register Study Group. Diabetes Care 1998;21:69-75
2. Galcerá-Tomás J, Melgarejo-Moreno A, Garcia-Alberola A, Rodriguez-Garcia P, Lozano-Martinez J, et al.: Prognostic significance of diabetes in acute myocardial infarction: are the differences linked to female gender? Int J Cardiol 1999;69:289-298
3. Gwilt DJ, Petri M, Lewis PW, Nattrass M, Pentecost BL: Myocardial infarct size and mortality in diabetic patients. Br Heart J 1985;54(4):466-472
4. Lehto S, Pyorala K, Miettinen H, Ronnemaa T, Palomaki P, et al.: Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1994;236:291-297
5. Granger CB, Califf RM, Young S, Candela R, Samaha J, et al.: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993;21(4):920-925
6. Mak KH, Moliterno DJ, Granger CB, Miller DP, White HD, et al., Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO)-1 Investigators: Influence of diabetes mellitus on clinical outcome in the thrombolytic area of acute myocardial infarction. J Am Coll Cardiol 1997;30:171-179
7. Fava S, Azzorpadi J, Agius-Muscat H: Outcome of unstable angina in patients with diabetes mellitus. Diabet Med 1997;14:209-213
8. Malmberg K, Yusuf S, Gerstein H, Brown J, Zhao F, et al., OASIS Registry Investigators: Impact of diabetes on long-term prognosis in patients with anstable angina and non-Q-wave myocardial infarction: results of the OASIS Registry. Circulation 2000;102:1014-1019
9. Gowda MS, Vacek JL, Hallas D: One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 1998;81:1067-1071
10. McGuire DK, Emanuelsson H, Granger CB, Magnus Ohman E, Moliterno DJ, et al., GUSTO-IIb Investigators. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes, Findings from the GUSTO-IIb Study. Eur Heart J 2000;21:750-1758
11. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, et al., GRACE Investigators: Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 2004;164:1457-1463
12. Hasdai D, Behar S, Boyko V, Battler A: Treatment modalities of diabetes mellitus and outcomes of acute coronary syndromes. Coron Artery Dis 2004;15:129-135
13. Pitsavos C, Panagiotakos DB, Antonoulas A, Zombolos S, Kogias Y, et al., Greek Study of Acute Coronary Syndromes Study Investigators. Epidemiology of acute coronary syndromes in a Mediterranean country: aims, design and baseline characteristics of the Greek study of acute coronary syndromes (GREECS). BMC Public Health 2005;5:23
14. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:502-1513
15. Braunwald E: Heart Disease (5th ed.) London: W.B. Saunders Company; 1997
16. Marchant B, Umachandran V, Stevenson R, Kopelman P, Timmis A: Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 1993;22: 1433-1437
17. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994;343:311-322
18. Hansen HH, Kjaergaard SC, Bulöw I, Fog L, Christensen PD: Thrombolytic therapy in diabetic patients with acute myocardial infarction. Diabetes Care 1996;19:1135-1137